Pomerantz Roger

Director at VIEWPOINT CORP · on record since Mar 18, 2026
Director at CONTRAFECT Corp · on record since Jul 29, 2014
Director at Seres Therapeutics, Inc. · on record since Jun 29, 2015
President and CEO at Seres Therapeutics, Inc. · on record since Jun 29, 2015
Director at Rubius Therapeutics, Inc. · on record since Jul 23, 2018
Director at NEOSE TECHNOLOGIES INC · on record since Jan 2, 2019
Chief Executive Officer at CONTRAFECT Corp · on record since Apr 4, 2019
Director at SUNESIS PHARMACEUTICALS INC · on record since Mar 30, 2021
Director at Indaptus Therapeutics, Inc. · on record since Aug 6, 2021

Insider trading activity of Pomerantz Roger

Transactions on record: 162; since Jun 29, 2015

Open-market buys: 2; $3.3K

Open-market sells: 49; $19.6M

Companies traded: 6; last filing Jun 11, 2025

Figures computed from official regulatory filings — methodology.

Companies where Pomerantz Roger has traded

Indaptus Therapeutics, Inc.8 tx · $500 · Jun 11, 2025
SUNESIS PHARMACEUTICALS INC33 tx · Nov 27, 2024
CONTRAFECT Corp4 tx · $1.7M · Feb 17, 2022
NEOSE TECHNOLOGIES INC2 tx · Jul 17, 2020
Seres Therapeutics, Inc.113 tx · $20.3M · Jun 14, 2019
Rubius Therapeutics, Inc.2 tx · $2.3K · Jul 23, 2018

Track record of Pomerantz Roger

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Pomerantz Roger

Co-insiders of Pomerantz Roger

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Indaptus Therapeutics, Inc.	Jun 11, 2025	AwardD	30,000	0.00 USD	$0	SEC
Indaptus Therapeutics, Inc.	Apr 11, 2025	OtherD	-500	0.50 USD	$250	SEC
Indaptus Therapeutics, Inc.	Apr 11, 2025	OtherD	-250	0.50 USD	$125	SEC
Indaptus Therapeutics, Inc.	Apr 11, 2025	OtherD	-250	0.50 USD	$125	SEC
SUNESIS PHARMACEUTICALS INC	Nov 27, 2024	ExerciseD	-9,034	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Nov 27, 2024	Exercise	9,034	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Sep 12, 2024	Exercise	9,034	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Sep 12, 2024	ExerciseD	-9,034	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Jun 24, 2024	AwardD	18,750	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Jun 24, 2024	AwardD	50,000	0.00 USD	$0	SEC
Indaptus Therapeutics, Inc.	Jun 7, 2024	AwardD	30,000	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	May 29, 2024	Exercise	9,035	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	May 29, 2024	ExerciseD	-9,035	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Feb 27, 2024	Exercise	9,034	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Feb 27, 2024	ExerciseD	-9,034	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Nov 28, 2023	Exercise	9,034	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Nov 28, 2023	ExerciseD	-9,034	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Aug 29, 2023	ExerciseD	-9,034	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Aug 29, 2023	Exercise	9,034	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Aug 18, 2023	AwardD	15,000	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Jun 9, 2023	AwardD	40,000	0.00 USD	$0	SEC
Indaptus Therapeutics, Inc.	May 30, 2023	AwardD	30,000	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	May 26, 2023	Exercise	9,035	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	May 26, 2023	ExerciseD	-9,035	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Feb 28, 2023	ExerciseD	-9,034	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Indaptus Therapeutics, Inc.	Jun 11, 2025	AwardD	30,000	0.00 USD	$0	SEC
Indaptus Therapeutics, Inc.	Apr 11, 2025	OtherD	-500	0.50 USD	$250	SEC
Indaptus Therapeutics, Inc.	Apr 11, 2025	OtherD	-250	0.50 USD	$125	SEC
Indaptus Therapeutics, Inc.	Apr 11, 2025	OtherD	-250	0.50 USD	$125	SEC
SUNESIS PHARMACEUTICALS INC	Nov 27, 2024	ExerciseD	-9,034	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Nov 27, 2024	Exercise	9,034	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Sep 12, 2024	Exercise	9,034	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Sep 12, 2024	ExerciseD	-9,034	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Jun 24, 2024	AwardD	18,750	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Jun 24, 2024	AwardD	50,000	0.00 USD	$0	SEC
Indaptus Therapeutics, Inc.	Jun 7, 2024	AwardD	30,000	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	May 29, 2024	Exercise	9,035	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	May 29, 2024	ExerciseD	-9,035	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Feb 27, 2024	Exercise	9,034	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Feb 27, 2024	ExerciseD	-9,034	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Nov 28, 2023	Exercise	9,034	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Nov 28, 2023	ExerciseD	-9,034	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Aug 29, 2023	ExerciseD	-9,034	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Aug 29, 2023	Exercise	9,034	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Aug 18, 2023	AwardD	15,000	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Jun 9, 2023	AwardD	40,000	0.00 USD	$0	SEC
Indaptus Therapeutics, Inc.	May 30, 2023	AwardD	30,000	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	May 26, 2023	Exercise	9,035	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	May 26, 2023	ExerciseD	-9,035	0.00 USD	$0	SEC
SUNESIS PHARMACEUTICALS INC	Feb 28, 2023	ExerciseD	-9,034	0.00 USD	$0	SEC